Company Announcement no. 11/2020

To: NASDAQ Copenhagen A/S                                          

Copenhagen, Denmark, 24 January 2020

Notice to Convene Extraordinary General Meeting

Upon request from Asahi Kasei Pharma Denmark A/S, the board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 (the "Company"), hereby convenes an extraordinary general meeting in the Company to be held on

Monday 17 February 2020 at 12:00 p.m. CET

at the offices of Plesner Law Firm, Amerika Plads 37, 2100 Copenhagen, Denmark.

Shareholders who have accepted the voluntary recommended public offer shall disregard this convening notice as such shareholders have no rights to attend and vote at the Extraordinary General Meeting as their shares are sold.

Agenda

1                    Election of new members of the board of directors of Veloxis Pharmaceuticals A/S (current members are expected to resign)

Please see attached document for complete proposals. 

For more information, please contact:

Veloxis Pharmaceuticals A/S

Craig A. Collard                                     Ira Duarte
President & CEO                                  CFO
Phone: +1 919 591 3090                      Phone: +1 919 591 3090
Email: cac@veloxis.com                       Email: idu@veloxis.com